Susan G. Komen®, the world’s leading breast cancer organization, recognized two widely respected and innovative breast cancer researchers this week, announcing that Donald McDonnell, Ph.D., and Laura Esserman, M.D., have been selected as this year’s recipients of the Brinker Awards – Komen’s highest scientific honor.
This year’s Brinker Award for Scientific Distinction in Clinical Research will be presented to Laura Esserman, M.D., M.B.A., Director, Carol Franc Buck Breast Care Center, Alfred A. de Lorimier Endowed Chair in General Surgery, Professor of Surgery and Radiology, University of California, San Francisco.
“Dr. Laura Esserman is an internationally recognized breast cancer surgeon and researcher who has spent her career at the University of California-San Francisco. Her groundbreaking work in the I-SPY and I-SPY2 clinical trials have revolutionized our understanding of neoadjuvant clinical trials as biomarker and novel therapeutic testing venues and have led the way for the development of several clinically important agents,” said Komen’s Chief Scientific Advisor, Dr. George Sledge, Jr. M.D., Professor of Medicine, Stanford University.